Managing DVT In Pregnancy: Protocols Discussed At Hospital Medicine 2017

Venous thromboembolism remains an important cause of maternal illness, and deep vein thrombosis (DVT) can be difficult to recognise during pregnancy. Leg swelling, discomfort, breathlessness and tachycardia may be attributed to normal physiological change, allowing a serious clot to progress. Hospital physicians therefore need a practical pathway that combines early suspicion, appropriate imaging and safe anticoagulation.

The educational themes associated with Hospital Medicine 2017 focused on evidence-based inpatient care, clinical decision-making and coordination between medical teams. The conference, held at Mandalay Bay in Las Vegas from 1–4 May 2017, also provided conference resources for clinicians reviewing research, patient safety and contemporary hospital protocols.

For Australian clinicians, the same principles apply within a different health system. A pregnant patient may first present to a GP, emergency department, maternity assessment unit or a rural hospital before being transferred to a tertiary service. Local protocols from state maternity networks, RANZCOG guidance and Therapeutic Guidelines should be checked alongside the patient’s obstetric, haematological and anaesthetic risks.

The central message is straightforward: treat suspected pregnancy-associated DVT seriously, confirm the diagnosis efficiently, and use an anticoagulant plan that accounts for gestation, delivery, renal function and breastfeeding. The following comparison summarises the practical choices commonly discussed in hospital medicine.

Recognising DVT In Pregnancy

Pregnancy produces venous dilation, increased blood volume and pressure from the enlarging uterus. These changes can make calf symptoms less specific, while the risk of thrombosis rises further with previous VTE, thrombophilia, immobility, obesity, infection, multiple pregnancy, pre-eclampsia or caesarean birth. A careful history should establish when symptoms began, whether they are unilateral, and whether there is chest pain, haemoptysis or sudden dyspnoea suggesting pulmonary embolism.

The left leg is frequently affected because of pelvic venous compression, although either leg may be involved. Whole-leg swelling, tenderness along the deep venous system and a clear difference in calf size should increase concern. Clinical prediction rules developed for non-pregnant adults should not be used uncritically, and a normal D-dimer should not be relied upon to exclude DVT in pregnancy. If clinical suspicion is meaningful, diagnostic imaging should proceed promptly.

When pulmonary embolism is possible, the patient needs an urgent assessment of airway, breathing and circulation, oxygenation and haemodynamic stability. A stable patient can undergo structured imaging, while shock, severe hypoxia or syncope requires emergency escalation and senior involvement. The risk of radiation from appropriately selected imaging is generally lower than the risk of missing a maternal pulmonary embolus.

Confirming The Diagnosis Safely

Compression duplex ultrasonography is the usual first investigation for suspected lower-limb DVT. It is non-invasive, widely available and avoids ionising radiation. A positive result warrants therapeutic anticoagulation unless a major contraindication exists. If the scan is technically limited or negative but symptoms remain convincing, clinicians should discuss repeat ultrasound, imaging of the iliac veins or magnetic resonance venography with radiology and obstetrics.

Pregnancy-associated clots can occur in the pelvic or iliac veins, where a standard leg ultrasound may miss them. Persistent whole-leg swelling, buttock or groin pain, or a strong clinical picture with an inconclusive scan should prompt a broader diagnostic strategy rather than reassurance. Australian hospitals may have different access to after-hours sonography, particularly outside Sydney, Melbourne, Brisbane and other major centres, so the escalation pathway should be clear.

Empirical anticoagulation may be appropriate while awaiting imaging when suspicion is high and the bleeding risk is acceptable. The decision should consider active bleeding, placenta-related complications, recent surgery, platelet count, renal function and the possibility of labour. Documentation should record the reason for treatment, the planned imaging and who is responsible for reviewing the result.

Choosing Anticoagulation

Therapeutic LMWH is generally preferred for confirmed DVT during pregnancy. It does not cross the placenta, has predictable pharmacokinetics and is suitable for outpatient or inpatient management. Enoxaparin is commonly used, with dosing based on the patient’s booking or early-pregnancy weight according to local policy. Renal impairment, extremes of body weight and recurrent thrombosis may require specialist input and, in selected cases, anti-Xa testing.

UFH remains useful when rapid offset or reversal is important. It may be selected near delivery, in severe renal impairment or when a procedure is likely soon. Intravenous UFH allows close titration in an unstable patient, while subcutaneous UFH may be considered in other circumstances. Protamine can partially or substantially reverse heparin effects, making UFH an important option when the clinical situation is changing quickly.

Warfarin is avoided during pregnancy because of fetal risks, particularly during early gestation and near delivery. Direct oral anticoagulants such as apixaban, rivaroxaban and dabigatran are generally avoided because pregnancy data remain limited and placental or breastmilk exposure is a concern. Treatment must also account for heparin-induced thrombocytopenia, allergies and bleeding. Platelet counts and renal function should be reviewed, with a clear handover to the GP and maternity team.

Planning Birth And The Postpartum Period

A woman receiving therapeutic LMWH should have an antenatal plan well before the expected birth. The plan should state when to stop injections if labour begins, who to contact, what to do if membranes rupture and whether induction is being considered. Neuraxial anaesthesia requires a safe interval after the last anticoagulant dose; commonly used intervals are longer for therapeutic dosing than for prophylactic dosing, and the local anaesthetic policy must take precedence.

Planned induction or caesarean birth may make anticoagulant timing more predictable, but spontaneous labour remains possible. If urgent birth is needed, the maternity, anaesthetic, haematology and neonatal teams must balance bleeding, thrombosis and anaesthetic risks. The patient should receive plain-language instructions, including the need to avoid taking another dose after labour starts until the treating team provides advice.

Anticoagulation usually continues for the remainder of pregnancy and for at least six weeks postpartum, with a total treatment period of at least three months. Breastfeeding-compatible options include LMWH, UFH and, in suitable postpartum circumstances, warfarin. Postnatal review should cover adherence, injection technique, wound or lochia concerns, mobility, contraception and warning symptoms of recurrent VTE.

Coordinating Safe Inpatient Care

The best protocol is a coordinated process rather than a medication order. Obstetric medicine, haematology, emergency medicine, radiology, pharmacy, midwifery and anaesthesia may all contribute. In a regional Queensland or Western Australian hospital, telehealth consultation and retrieval planning may be needed; the patient should not be left to navigate those arrangements alone. A named clinician should own the diagnostic result and follow-up plan.

Medication reconciliation is particularly important when a patient moves between emergency care, a maternity ward and home. The record should include the indication, dose, weight used, renal function, start date, intended duration, missed-dose advice and planned review. Discharge information should specify whether the prescription is supplied through the hospital, community pharmacy or another arrangement, since access and cost can affect adherence.

Communication also includes how staff respond when a frightened or distressed patient refuses examination or treatment. Techniques described in safe de-escalation skills are relevant: use a calm tone, explain the immediate concern, offer choices where possible and involve a support person or interpreter. Respectful communication can improve cooperation without minimising risk or applying unnecessary restraint.

Monitoring And Updating The Protocol

Follow-up should assess symptom improvement, bleeding, injection-site problems, platelet count when clinically indicated and renal function where dosing depends on it. New chest pain, worsening breathlessness, collapse or haemoptysis requires urgent reassessment for pulmonary embolism. Recurrent symptoms should not be dismissed as treatment failure until adherence, dose, diagnosis and alternative causes have been reviewed.

Hospitalists should also remember that pregnancy care intersects with other inpatient problems. Dehydration, sepsis, pre-eclampsia and nephrotoxic exposure can change renal clearance and anticoagulant safety. A structured approach to kidney function, such as the principles discussed in updated acute kidney injury criteria, helps identify when a previously suitable LMWH plan needs specialist reassessment.

Protocols from 2017 remain useful for their emphasis on early recognition, LMWH-based treatment and multidisciplinary planning, but local recommendations and evidence have continued to develop. Australian services should align any conference-derived framework with current state guidance, hospital medicines policy, obstetric anaesthesia rules and contemporary national recommendations.

The key points to remember are to investigate credible symptoms promptly, use compression ultrasound appropriately, favour pregnancy-compatible anticoagulation, plan ahead for birth and maintain a clear handover from hospital to community care. In pregnancy-associated DVT, safe treatment depends on timely diagnosis and coordinated decisions across the whole maternity journey.